Autologous mesenchymal stem cells in chronic spinal cord injury
Author:
Publisher
Informa UK Limited
Subject
Clinical Neurology,General Medicine,Surgery
Link
http://www.tandfonline.com/doi/pdf/10.3109/02688697.2010.550658
Reference60 articles.
1. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey?
2. Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury
3. Can cell therapy heal a spinal cord injury?
4. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adverse events of cell therapy clinical trials in human chronic spinal cord injury, a systematic review and meta-analysis;Regenerative Therapy;2024-12
2. Current status and future perspectives on stem cell transplantation for spinal cord injury;World Journal of Transplantation;2024-03-18
3. Mesenchymal Stem Cells as Modern Off-the-Shelf Products: From Research Perspectives to Clinical Practice;Handbook of Stem Cell Applications;2024
4. Systematic Review of Cell Therapy Efficacy in Human Chronic Spinal Cord Injury;Tissue Engineering Part B: Reviews;2023-12-26
5. Mesenchymal Stem Cell Therapy in Traumatic Spinal Cord Injury: A Systematic Review;International Journal of Molecular Sciences;2023-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3